FENNEC PHARMACEUTICALS INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $36.8M | $26.6M | $13.3M | $23.8M | $21.1M | $30.3M | $13.7M | $22.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $67.0M | $44.1M | $26.9M | $26.7M | $22.4M | $31.4M | $13.9M | $23.0M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $70.6M | $44.9M | $26.9M | $26.9M | $22.4M | $31.4M | $14.1M | $23.0M |
| Liabilities | ||||||||
| Accounts Payable | $4.6M | $3.2M | $3.8M | $2.4M | $777.0K | $1.6M | $1.6M | $1.0M |
| Total Current Liabilities | $10.5M | $6.9M | $7.6M | $4.6M | $1.7M | $2.3M | $2.3M | $1.6M |
| Long-Term Debt | — | $19.3M | $30.9M | $24.9M | — | — | — | — |
| Total Liabilities | $35.1M | $50.8M | $38.5M | $29.5M | $6.6M | $2.3M | $2.3M | $1.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-229.4M | $-219.7M | $-219.2M | $-203.2M | $-179.5M | $-162.1M | $-144.0M | $-131.3M |
| Total Stockholders' Equity | $35.5M | $-5.9M | $-11.6M | $-2.6M | $15.8M | $29.1M | $11.9M | $21.3M |